DOPA-responsive dystonia. From causative gene to molecular mechanism.
Ichinose
H
H
Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
Suzuki
T
T
Inagaki
H
H
Ohye
T
T
Nagatsu
T
T
D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D015259:Dopamine Agents / Q000627:therapeutic use*; D004421:Dystonia / Q000188:drug therapy* / Q000235:genetics*; D005192:Family Health; D006801:Humans; D010375:Pedigree
D015259:Dopamine Agents; D004295:Dihydroxyphenylalanine